Global Contact Lenses And Solutions Industry
Menicon Takes Over Tomey II-58
DAC International Acquires Contamac's Opteq Technology II-58
6. CORPORATE ACTIVITY IN RECENT PAST - A PERSPECTIVE BUILDER II-59
Abbott Laboratories Acquires Advanced Medical Optics II-59
Coastal Contacts Acquires European Company, EyePassion II-59 Hilsinger Acquires C-Clear II-59 Unilens Vision Acquires Aero Contact Lens II-59 Menicon to Take Over David Thomas Contact Lenses II-60 Lens Dynamics to Merge with Firestone Optics II-60 Hoya Corp. to Merge with Hoya Healthcare II-60 Bausch & Lomb and Santen Ink Licensing Agreement II-60 Indo Internacional and Hoya Vision Care Announce Agreement II-60 CooperVision Renames Biomedics® EP as Proclear® EP II-61 Bausch & Lomb to Consolidate Contact Lens Production II-61 Specsaver Establishes New Plant in Mateszalka II-61 Vision Express to Open 500 Eyewear Outlets in India II-61 Odyssey India to Launch The Eyewear Store in India II-62 Hoya to Open Multiple Stores in China II-62 CooperVision to Shut Down US-based Manufacturing Facility II-62 Bausch & Lomb Receive New Technology Intraocular Lens Designation II-62 Oculus Divests Contact Lens and Eye Care Business II-62 Novartis Acquires Minority Stake in Alcon II-63 Bausch & Lomb Acquires eyeonics II-63 Menicon Acquires Rose K II-63 Houchens Acquires Cohen Fashion II-63 AMO and IER Enter Collaboration to Develop Contact Lens Care Solutions II-63 Sauflon to Construct Contact Lens Factory II-64 7. FOCUS ON SELECT GLOBAL PLAYERS II-65 Abbott Medical Optics, Inc. ( USA) II-65 Alcon, Inc. ( Switzerland) II-65 Bausch & Lomb, Inc. ( USA) II-66 CooperVision, Inc. ( USA) II-66 Ginko International Co., Ltd. ( China) II-67 Vistakon ( USA) II-67 8. GLOBAL MARKET PERSPECTIVE II-68 Table 9: World Recent Past, Current & Future Analysis forSelect the service that is right for you!
COMPARE ALL SERVICESAction Alerts PLUS
TRY IT FREEJim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.
Product Features:
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
- Weekly roundups
TheStreet Quant Ratings
TRY IT FREENew! $49.95/yr
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
Product Features:
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Upgrade/downgrade alerts
Stocks Under $10
TRY IT FREEDavid Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.
Product Features:
- Model portfolio
- Stocks trading below $10
- Intraday trade alerts
- Weekly roundups
Dividend Stock Advisor
TRY IT FREEJim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.
Product Features:
- Diversified model portfolio of dividend stocks
- Alerts when market news affect the portfolio
- Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
TRY IT FREEAll of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.
Product Features:
- Real Money + Doug Kass + 15 more Wall Street Pros
- Intraday commentary & news
- Ultra-actionable trading ideas
Options Profits
TRY IT FREEOur options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.
Product Features:
- 100+ monthly options trading ideas
- Actionable options commentary & news
- Real-time trading community
- Options TV
